RNA Medicines Gain Ground
Vaccine proof, new chemistries and cheaper manufacture open the field; wins go to teams with tissue-targeted delivery, repeat-dose safety, and pharma ties.
Context: Comanche Biopharma
View Details
Agentic Deep Research
Email a link to agent@olymposhq.com with subject "fetch" to get your analysis results.
Page 4
Materials And Chemistry Bets
Cheaper compute and climate policy pull materials startups; those with proprietary lab loops, physics-plus-ML methods, and tight industry ties win.
Context: cusp.ai
View Details
New Defenses For Fraud
Rules tighten and faster pay rails boost fraud; winners ship real-time checks, clear audit trails, and fast links to bank data.
Context: Taktile - The Agentic Decision Platform
View Details
Startups Tackling Cyber Risk
Cloud sprawl and stricter rules raise stakes; winners ship automated fixes, real-time coverage, and painless setup across stacks.
Context: Dux Security | Agentic Exposure Management
View Details
Practical Finance Builders
Data loads swell and rates bite; teams with deep finance craft and live links to source data take share.
Context: Hanover Park - AI-native fund administrator
View Details
Guardrails For Machine Learning
As big models spread and new laws bite, winners offer live checks, risk watch, and drop-in fit with current build tools.
Context: Goodfire AI
View Details
Total Overview
3100
Companies
120608
Headcount
$76.2B
Total Raised
Frequently Asked Questions
Learn more about Olympos and how our VC services can transform your sourcing process
Have more questions about Olympos?
Contact Us